Recent News
October 19, 2026
Investment firm TCGX picks migraine biotech TriGemX to take public via SPAC
TriGemX Bio, formerly known as Kallyope, is commercializing technology developed by Columbia's Dr. Charles Zuker, Dr. Tom Maniatis, and Dr. Richard Axel.
October 15, 2026
The Best Inventions of 2026
NOVAKnee, a “living knee” implant, has been named one of TIME’s Best Inventions of 2026. The project is co-led by Columbia's Dr. Clark Hung and Dr. Nadeen Chahine.
October 09, 2026
Ferass Abuzaina named Worldwide President of Surgery at BD
Ferass Abuzaina is one of CTV's Executives in Residence.